PT  - JOURNAL ARTICLE
AU  - Shuman, Jill
ED  - Mont, Lluis
TI  - Ablation versus Antiarrhythmic Drugs in Persistent AF: The SARA Trial
DP  - 2014 Sep 01
TA  - MD Conference Express
PG  - 24--25
VI  - 14
IP  - 21
4099  - http://mdc.sagepub.com/content/14/21/24.2.short
4100  - http://mdc.sagepub.com/content/14/21/24.2.full
AB  - Compared with antiarrhythmic drug therapy (ADT), catheter ablation (CA) is an effective treatment for paroxysmal atrial fibrillation (PAF) [Jaïs P et al. Circulation 2008]. Although CA is recommended as an indication for patients with PAF by current US and European guidelines [Camm A et al. Eur Heart J 2012; Fuster V et al. J Am Coll Cardiol 2011], its use by patients with persistent AF is unclear and even controversial. This article reviews data from the Study of Ablation Versus Antiarrhythmic Drugs in Persistent Atrial Fibrillation [SARA; Mont L et al. Eur Heart J 2014].